New patent for United Therap drug TYVASO DPI

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for TYVASO+DPI
Annual Drug Patent Expirations for TYVASO+DPI

Tyvaso Dpi is a drug marketed by United Therap and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

Drug patent litigation for TYVASO DPI.

This drug has one hundred and thirty-two patent family members in twenty countries.

The generic ingredient in TYVASO DPI is treprostinil. One supplier is listed for this compound. Additional details are available on the treprostinil profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top